Winstrol (Oral)
Stanozolol · Winny
Oral stanozolol; cutting agent, joint pain common. Simple model — peak calibrated.
Key takeaways
- Oral DHT derivative that does not aromatize — strength and hardness without water retention.
- ~9-hour half-life means twice-daily dosing; uniquely lowers SHBG, raising free hormone fractions.
- Moderate hepatotoxicity plus strong HDL suppression — lipids are the biggest measurable risk.
- Joint pain is a common complaint as water and synovial lubrication drop.
Overview
What it is
Winstrol (stanozolol) is an oral DHT-derived anabolic steroid, 17-alpha-alkylated with an added pyrazole ring, developed in 1962. It builds strength without estrogenic water retention and uniquely lowers SHBG, which raises the free fraction of other hormones in the system. Its remaining US approval is for hereditary angioedema.
Pharmacokinetics
The ~9-hour half-life drives the standard twice-daily split dosing. Oral bioavailability is effectively complete thanks to the 17-alpha-methyl group, the same modification responsible for its liver strain.
Harm reduction
It does not aromatize, so the concerns are hepatic and metabolic: moderate hepatotoxicity, marked HDL suppression, and LDL elevation. Joint pain is commonly reported as water and synovial lubrication drop. Liver enzymes and a full lipid panel are the core monitoring set, and HPTA suppression is dose-dependent.
Reported dosing protocols
Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Hereditary angioedema (label) | 2 mg | Oral | 1–3× daily | Ongoing (tapered) |
| Performance (community) | 20–50 mg daily | Oral | Split 2× daily | 6–8 weeks |
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 9 hours
- Cmax
- 49.9 ng/dL
- Bioavailability
- 100%
- Typical dose
- 20–50 mg
Harm reduction
- Aromatizes
- No
- DHT derivative
- Yes
- Hepatotoxicity
- moderate
- Injection frequency
- Oral, 2×/day
Frequently asked questions
Oral vs injectable Winstrol — is there a difference?
Same molecule. The injectable is a water-based microcrystal suspension with a ~3.4-day apparent half-life and lower hepatotoxicity since it skips first-pass metabolism. The oral clears in ~9 hours but stresses the liver more.
Why do joints hurt on Winstrol?
Stanozolol strips water retention broadly, including synovial fluid, so joint lubrication drops and heavy lifting on top of that produces the commonly reported joint pain. It reverses after discontinuation.
Does Winstrol affect other compounds in a stack?
Yes. It lowers SHBG more than most AAS, which raises the free (active) fraction of every other hormone in the system — amplifying both the effects and the side effects of anything run alongside it.
References
- Llewellyn Anabolics (11th ed.) — Cmax calibrated to ng/dL serum peak. Stanozolol PK from Llewellyn; oral bioavailability from ChEBI.
- PubMed — stanozolol PK — Stanozolol PK reference; oral bioavailability from ChEBI per entry notes.
Related articles
Related compounds
Halotestin
Extremely hepatotoxic oral; pure strength/aggression, minimal hypertrophy.
Anadrol
Potent oral mass builder; high water retention and significant hepatotoxicity.
Dianabol
Classic oral mass builder; short half-life, strong aromatization. Simple model — peak calibrated.
Protocols featuring Winstrol (Oral)
Comments
Loading comments…